GammaTile®

DEVICE2 trials

Sponsors

GT Medical Technologies, Inc., University of California, Irvine

Conditions

AstrocytomaElderly GBMElderly GlioblastomaGBMGlioblastomaGliomaGlioma, MalignantOligodendroglioma

Phase 2

Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Tx Treated With Cesium-131 GammaTile®

Not yet recruitingNCT07821112

University of California, IrvineAstrocytoma, Elderly GBM, Elderly Glioblastoma +5

Start: 2026-10-01End: 2029-10-01Target: 20Updated: 2026-09-15

Phase 3

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

RecruitingNCT07195591

GT Medical Technologies, Inc.Glioblastoma

Start: 2025-12-10End: 2031-12-01Target: 766Updated: 2026-09-18

Related Papers

BRIDGES: A phase 3 randomized trial of immediate postoperative cesium-131 tile-based radiation therapy followed by abbreviated chemoradiation for newly diagnosed glioblastoma (NCT07195591).

Journal of Clinical Oncology2026-05-28

Outcomes of a feasibility and safety trial of tile-based radiation therapy with cesium-131 followed by external beam radiation therapy with concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma (NCT05342883).

Journal of Clinical Oncology2026-05-27